These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1772 related articles for article (PubMed ID: 23635390)

  • 1. Validity of dual MRI and F-FDG PET imaging in predicting vulnerable and inflamed carotid plaque.
    Saito H; Kuroda S; Hirata K; Magota K; Shiga T; Tamaki N; Yoshida D; Terae S; Nakayama N; Houkin K
    Cerebrovasc Dis; 2013; 35(4):370-7. PubMed ID: 23635390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contemporary carotid imaging: from degree of stenosis to plaque vulnerability.
    Brinjikji W; Huston J; Rabinstein AA; Kim GM; Lerman A; Lanzino G
    J Neurosurg; 2016 Jan; 124(1):27-42. PubMed ID: 26230478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-risk plaque features can be detected in non-stenotic carotid plaques of patients with ischaemic stroke classified as cryptogenic using combined (18)F-FDG PET/MR imaging.
    Hyafil F; Schindler A; Sepp D; Obenhuber T; Bayer-Karpinska A; Boeckh-Behrens T; Höhn S; Hacker M; Nekolla SG; Rominger A; Dichgans M; Schwaiger M; Saam T; Poppert H
    Eur J Nucl Med Mol Imaging; 2016 Feb; 43(2):270-279. PubMed ID: 26433367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High resolution FDG-microPET of carotid atherosclerosis: plaque components underlying enhanced FDG uptake.
    Liu J; Kerwin WS; Caldwell JH; Ferguson MS; Hippe DS; Alessio AM; Martinez-Malo V; Pimentel K; Miyaoka RS; Kohler TR; Hatsukami TS; Yuan C
    Int J Cardiovasc Imaging; 2016 Jan; 32(1):145-52. PubMed ID: 26280889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging Intraplaque Inflammation in Carotid Atherosclerosis With 18F-Fluorocholine Positron Emission Tomography-Computed Tomography: Prospective Study on Vulnerable Atheroma With Immunohistochemical Validation.
    Vöö S; Kwee RM; Sluimer JC; Schreuder FH; Wierts R; Bauwens M; Heeneman S; Cleutjens JP; van Oostenbrugge RJ; Daemen JW; Daemen MJ; Mottaghy FM; Kooi ME
    Circ Cardiovasc Imaging; 2016 May; 9(5):. PubMed ID: 27162131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-resolution magnetic resonance imaging of carotid atherosclerosis identifies vulnerable carotid plaques.
    Millon A; Mathevet JL; Boussel L; Faries PL; Fayad ZA; Douek PC; Feugier P
    J Vasc Surg; 2013 Apr; 57(4):1046-1051.e2. PubMed ID: 23375613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Higher reliability of 18F-FDG target background ratio compared to standardized uptake value in vulnerable carotid plaque detection: a pilot study.
    Niccoli Asabella A; Ciccone MM; Cortese F; Scicchitano P; Gesualdo M; Zito A; Di Palo A; Angiletta D; Regina G; Marzullo A; Rubini G
    Ann Nucl Med; 2014 Jul; 28(6):571-9. PubMed ID: 24737136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigating vulnerable atheroma using combined (18)F-FDG PET/CT angiography of carotid plaque with immunohistochemical validation.
    Menezes LJ; Kotze CW; Agu O; Richards T; Brookes J; Goh VJ; Rodriguez-Justo M; Endozo R; Harvey R; Yusuf SW; Ell PJ; Groves AM
    J Nucl Med; 2011 Nov; 52(11):1698-703. PubMed ID: 21990578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PET/CT imaging of integrin αvβ3 expression in human carotid atherosclerosis.
    Beer AJ; Pelisek J; Heider P; Saraste A; Reeps C; Metz S; Seidl S; Kessler H; Wester HJ; Eckstein HH; Schwaiger M
    JACC Cardiovasc Imaging; 2014 Feb; 7(2):178-87. PubMed ID: 24412187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 18FDG PET and ultrasound echolucency in carotid artery plaques.
    Graebe M; Pedersen SF; Højgaard L; Kjaer A; Sillesen H
    JACC Cardiovasc Imaging; 2010 Mar; 3(3):289-95. PubMed ID: 20223427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of inflamed atherosclerotic lesions in vivo using PET-CT.
    Jezovnik MK; Zidar N; Lezaic L; Gersak B; Poredos P
    Inflammation; 2014 Apr; 37(2):426-34. PubMed ID: 24282108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural history of atherosclerotic disease progression as assessed by (18)F-FDG PET/CT.
    Hetterich H; Rominger A; Walter L; Habs M; Volpers S; Hacker M; Reiser MF; Bartenstein P; Saam T
    Int J Cardiovasc Imaging; 2016 Jan; 32(1):49-59. PubMed ID: 25898891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New insight of functional molecular imaging into the atheroma biology: 18F-NaF and 18F-FDG in symptomatic and asymptomatic carotid plaques after recent CVA. Preliminary results.
    Quirce R; Martínez-Rodríguez I; Banzo I; Jiménez-Bonilla J; Martínez-Amador N; Ibáñez-Bravo S; López-Defilló J; Jiménez-Alonso M; Revilla MA; Carril JM
    Clin Physiol Funct Imaging; 2016 Nov; 36(6):499-503. PubMed ID: 26147617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advanced ultrasound methods in assessment of carotid plaque instability: a prospective multimodal study.
    Zamani M; Skagen K; Scott H; Russell D; Skjelland M
    BMC Neurol; 2020 Jan; 20(1):39. PubMed ID: 31996153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multimodality imaging of atherosclerotic plaque activity and composition using FDG-PET/CT and MRI in carotid and femoral arteries.
    Silvera SS; Aidi HE; Rudd JH; Mani V; Yang L; Farkouh M; Fuster V; Fayad ZA
    Atherosclerosis; 2009 Nov; 207(1):139-43. PubMed ID: 19467659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multimodality imaging of carotid artery plaques: 18F-fluoro-2-deoxyglucose positron emission tomography, computed tomography, and magnetic resonance imaging.
    Kwee RM; Teule GJ; van Oostenbrugge RJ; Mess WH; Prins MH; van der Geest RJ; Ter Berg JW; Franke CL; Korten AG; Meems BJ; Hofman PA; van Engelshoven JM; Wildberger JE; Kooi ME
    Stroke; 2009 Dec; 40(12):3718-24. PubMed ID: 19875738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative assessment of atherosclerotic plaques on (18)F-FDG PET/MRI: comparison with a PET/CT hybrid system.
    Li X; Heber D; Rausch I; Beitzke D; Mayerhoefer ME; Rasul S; Kreissl M; Mitthauser M; Wadsak W; Hartenbach M; Haug A; Zhang X; Loewe C; Beyer T; Hacker M
    Eur J Nucl Med Mol Imaging; 2016 Jul; 43(8):1503-12. PubMed ID: 26816195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients.
    Tawakol A; Migrino RQ; Bashian GG; Bedri S; Vermylen D; Cury RC; Yates D; LaMuraglia GM; Furie K; Houser S; Gewirtz H; Muller JE; Brady TJ; Fischman AJ
    J Am Coll Cardiol; 2006 Nov; 48(9):1818-24. PubMed ID: 17084256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carotid Plaque Lipid Content and Fibrous Cap Status Predict Systemic CV Outcomes: The MRI Substudy in AIM-HIGH.
    Sun J; Zhao XQ; Balu N; Neradilek MB; Isquith DA; Yamada K; Cantón G; Crouse JR; Anderson TJ; Huston J; O'Brien K; Hippe DS; Polissar NL; Yuan C; Hatsukami TS
    JACC Cardiovasc Imaging; 2017 Mar; 10(3):241-249. PubMed ID: 28279371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined 18F-FDG PET-CT and DCE-MRI to assess inflammation and microvascularization in atherosclerotic plaques.
    Truijman MT; Kwee RM; van Hoof RH; Hermeling E; van Oostenbrugge RJ; Mess WH; Backes WH; Daemen MJ; Bucerius J; Wildberger JE; Kooi ME
    Stroke; 2013 Dec; 44(12):3568-70. PubMed ID: 24114456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 89.